MedChew GB

MedChew GB is a medicated chewing gum formulation containing cannabinoids, developed using APIRx/Incannex “medicated chewing gum technology” to deliver active ingredients via the oral mucosa for faster onset and improved bioavailability compared with conventional oral cannabis products.[2][8][12][10] The gum is designed as a transmucosal, controlled‑release dosage form that bypasses much of first‑pass metabolism and may reduce gastrointestinal intolerance often associated with ingestible cannabinoid oils or capsules.[2][8][12] MedChew GB is positioned as a pharmaceutical cannabinoid product within a broader portfolio of cannabinoid chewing gum compositions targeted to indications such as inflammatory and neurologic conditions, although specific active components and clinical indications for MedChew GB itself have not been fully disclosed publicly.[2][8][12]

Brand names

MedChew GB